Trean Insurance Group (TIG) Stock Price, News & Analysis

Trean Insurance Group, Inc. (NASDAQ:TIG) issued its quarterly earnings results on Wednesday, November, 10th. The company reported $0.15 EPS for the quarter, missing analysts' consensus estimates of $0.20 by $0.05. The business had revenue of $56.94 million for the quarter, compared to analyst estimates of $59.64 million. Trean Insurance Group had a positive trailing twelve-month return on equity of 2.04% and a negative net margin of 21.75%. During the same quarter last year, the firm earned $0.21 earnings per share.

42 employees have rated Trean Insurance Group Chief Executive Officer Tim Griffiths on Glassdoor.com. Tim Griffiths has an approval rating of 45% among the company's employees. This puts Tim Griffiths in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Trean Insurance Group investors own include Editas Medicine (EDIT), Agenus (AGEN), Pharming Group (PHGUF), Galapagos (GLPG), NewLink Genetics (NLNK), ING Groep (ING), Cytori Therapeutics (CYTX), Hemispherx BioPharma (HEB), Teva Pharmaceutical Industries (TEVA) and Ultra Clean (UCTT).

Trean Insurance Group (TIG) raised $150 million in an initial public offering on Thursday, July 16th 2020. The company issued 10,700,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan, Evercore ISI and William Blair acted as the underwriters for the IPO and JMP Securities was co-manager.